hypoxanthine has been researched along with Malaria, Falciparum in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Burckhardt, BB; de Carvalho, LP; Held, J; Herrmann, J; Knaab, T; Kreidenweiss, A; Kurz, T; Mavraj-Husejni, A; Müller, R; Niepoth, E | 1 |
| Kim, K; McDonald, TV; Waller, KL | 1 |
| An, SS; Ariey, F; Chotivanich, K; Das, D; Day, NP; Dondorp, AM; Hanpithakpong, W; Herdman, T; Imwong, M; Lee, SJ; Lim, P; Lindegardh, N; Lwin, KM; Nosten, F; Phyo, AP; Ringwald, P; Silamut, K; Singhasivanon, P; Socheat, D; Tarning, J; White, NJ; Yeung, S; Yi, P | 1 |
| Basco, L; Boyer, J; Ibrahim, H; Nepveu, F; Tahar, R; Thompson, E; Vivas, L | 1 |
| Kyle, DE; Mutka, T; Patel, J; Sparks, K; Tucker, MS | 1 |
| Burrows, JN; Crespo, B; De-Cózar, C; Ding, XC; Gamo, FJ; García-Bustos, JF; Llergo, JL; Sanz, LM | 1 |
| Davis, TM; Hamzah, J; Skinner-Adams, TS | 1 |
| Carter, M; Day, KP; Drain, J; Ferguson, DJ; Hajduk, SL; Imrie, H; Schiflett, A | 1 |
| Ramanitrahasimbola, D; Rasoanaivo, P; Ratsimamanga, S; Vial, H | 1 |
| Bröer, S; Downie, MJ; Howitt, SM; Kirk, K; Saliba, KJ | 1 |
| Adagu, I; Dar, O; Khan, MS | 1 |
1 trial(s) available for hypoxanthine and Malaria, Falciparum
| Article | Year |
|---|---|
Artemisinin resistance in Plasmodium falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Drug Resistance; Drug Therapy, Combination; Follow-Up Studies; Humans; Hypoxanthine; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Genetic; Recurrence; Young Adult | 2009 |
10 other study(ies) available for hypoxanthine and Malaria, Falciparum
| Article | Year |
|---|---|
Quantification of Plasmodium falciparum HRP-2 as an alternative method to [
Topics: Animals; Antimalarials; Chloroquine; Hypoxanthine; Malaria, Falciparum; Parasites; Plasmodium falciparum | 2023 |
Plasmodium falciparum: growth response to potassium channel blocking compounds.
Topics: Animals; Antimalarials; Apamin; Bicuculline; Humans; Hypoxanthine; Indoles; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Potassium Channel Blockers; Tritium; Tubocurarine | 2008 |
Indolone-N-oxide derivatives: in vitro activity against fresh clinical isolates of Plasmodium falciparum, stage specificity and in vitro interactions with established antimalarial drugs.
Topics: Adult; Antimalarials; Artemisinins; Cameroon; Chloroquine; Drug Interactions; Drug Resistance; Female; Humans; Hypoxanthine; Indoles; Malaria, Falciparum; Male; Nitrogen Oxides; Oxidation-Reduction; Parasitic Sensitivity Tests; Plasmodium falciparum | 2011 |
Phenotypic and genotypic analysis of in vitro-selected artemisinin-resistant progeny of Plasmodium falciparum.
Topics: Antimalarials; Artemisinins; Benzothiazoles; Cell Culture Techniques; Diamines; Dose-Response Relationship, Drug; Drug Resistance; Erythrocytes; Gene Dosage; Genotype; Humans; Hypoxanthine; Inhibitory Concentration 50; Malaria, Falciparum; Merozoites; Microscopy; Multidrug Resistance-Associated Proteins; Organic Chemicals; Parasitic Sensitivity Tests; Phenotype; Plasmodium falciparum; Quinolines; Recurrence | 2012 |
P. falciparum in vitro killing rates allow to discriminate between different antimalarial mode-of-action.
Topics: Animals; Antimalarials; Cell Culture Techniques; Drug Evaluation, Preclinical; Humans; Hypoxanthine; Inhibitory Concentration 50; Malaria, Falciparum; Plasmodium falciparum; Reproducibility of Results; Time Factors; Treatment Outcome | 2012 |
In vitro antimalarial activity of retinoids and the influence of selective retinoic acid receptor antagonists.
Topics: Animals; Anthracenes; Antimalarials; Benzoates; Chromans; Drug Interactions; Hypoxanthine; Inhibitory Concentration 50; Malaria, Falciparum; Plasmodium falciparum; Pyrroles; Receptors, Retinoic Acid; Retinoids; Tretinoin; Vitamin A | 2003 |
Light and electron microscopical observations of the effects of high-density lipoprotein on growth of Plasmodium falciparum in vitro.
Topics: Animals; Erythrocytes; Flow Cytometry; Humans; Hypoxanthine; Lipoproteins, HDL; Lipoproteins, LDL; Malaria, Falciparum; Microscopy, Electron; Plasmodium falciparum | 2004 |
Malagashanine potentiates chloroquine antimalarial activity in drug resistant Plasmodium malaria by modifying both its efflux and influx.
Topics: Alkaloids; Animals; Antimalarials; Chloroquine; Culture Media; Drug Resistance; Drug Synergism; Erythrocytes; Glucose; Hypoxanthine; Life Cycle Stages; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Time Factors | 2006 |
Purine nucleobase transport in the intraerythrocytic malaria parasite.
Topics: Adenine; Adenosine Triphosphate; Animals; Biological Transport; Cells, Cultured; Erythrocytes; Hypoxanthine; Malaria, Falciparum; Nucleobase Transport Proteins; Nucleobase, Nucleoside, Nucleotide, and Nucleic Acid Transport Proteins; Oocytes; Parasitology; Plasmodium falciparum; Protozoan Proteins; Xenopus laevis | 2008 |
The potential use of methotrexate in the treatment of falciparum malaria: in vitro assays against sensitive and multidrug-resistant falciparum strains.
Topics: Animals; Antimalarials; Chloroquine; Drug Resistance, Multiple; Humans; Hypoxanthine; Malaria, Falciparum; Methotrexate; Nucleic Acid Synthesis Inhibitors; Parasitic Sensitivity Tests; Plasmodium falciparum; Tritium | 2008 |